Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
BCB Bancorp
BCBP
$173M
| $166K | ﹤0.01% |
12,015
+644
| +6% | +$8.46K |
|
3752
Star Bulk Carriers
SBLK
$3.21B
| $166K | ﹤0.01% |
+11,276
| New | +$146K |
|
|
EVFM
3753
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $166K | ﹤0.01% |
6,281
+2,624
| +72% | +$119K |
|
3754
Cadiz
CDZI
$251M
| $164K | ﹤0.01% |
17,029
+10,453
| +159% | +$112K |
|
3755
BayCom
BCML
$329M
| $163K | ﹤0.01% |
9,009
+5,347
| +146% | +$87.4K |
|
|
CWBC
3756
Community West Bancshares
CWBC
$679M
| $163K | ﹤0.01% |
8,837
+5,426
| +159% | +$94.7K |
|
|
TYME
3757
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $163K | ﹤0.01% |
91,642
+69,214
| +309% | +$144K |
|
|
FSFG
3758
DELISTED
First Savings Financial Group
FSFG
| $162K | ﹤0.01% |
7,227
+2,886
| +66% | +$62K |
|
3759
CRH
CRH
$63.2B
| $161K | ﹤0.01% |
3,418
-3,363
| -50% | -$151K |
|
3760
Endava
DAVA
$158M
| $161K | ﹤0.01% |
1,908
+1,833
| +2,444% | +$153K |
|
3761
Ovid Therapeutics
OVID
$414M
| $161K | ﹤0.01% |
40,077
+24,718
| +161% | +$82.1K |
|
3762
Concrete Pumping Holdings
BBCP
$490M
| $160K | ﹤0.01% |
21,718
+13,332
| +159% | +$80.1K |
|
3763
Peabody Energy
BTU
$2.6B
| $160K | ﹤0.01% |
52,470
+32,211
| +159% | +$121K |
|
3764
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
| $160K | ﹤0.01% |
4,000
-18,900
| -83% | -$696K |
|
3765
Western New England Bancorp
WNEB
$259M
| $158K | ﹤0.01% |
18,807
+11,439
| +155% | +$87.3K |
|
3766
Orion Energy Systems
OESX
$41M
| $157K | ﹤0.01% |
2,261
+1,388
| +159% | +$130K |
|
3767
Smith Micro Software
SMSI
$14.5M
| $157K | ﹤0.01% |
716
-60
| -8% | -$15.9K |
|
3768
Verrica Pharmaceuticals
VRCA
$89.7M
| $157K | ﹤0.01% |
1,040
+638
| +159% | +$88.3K |
|
|
TREC
3769
DELISTED
Trecora Resources
TREC
| $157K | ﹤0.01% |
20,196
+12,398
| +159% | +$90.3K |
|
|
BACK
3770
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $156K | ﹤0.01% |
3,157
| – | – |
|
|
KIN
3771
DELISTED
Kindred Biosciences, Inc.
KIN
| $155K | ﹤0.01% |
31,146
+19,119
| +159% | +$92.3K |
|
3772
CALL
AstraZeneca
AZN
$263B
| $154K | ﹤0.01% |
1,550
-4,700
| -75% | -$472K |
|
3773
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $154K | ﹤0.01% |
2,784
| – | – |
|
3774
Vanguard FTSE Pacific ETF
VPL
$8.08B
| $154K | ﹤0.01% |
1,891
| – | – |
|
3775
Wave Life Sciences
WVE
$1.09B
| $154K | ﹤0.01% |
27,408
-197,072
| -88% | -$1.89M |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.